The Management of Medical Precision Implants, S.A. (hereinafter MPI) has established a policy aligned with the previously defined vision and strategy.

It provides a reference framework for setting and reviewing business objectives, which are periodically reviewed by Management to ensure the availability of necessary resources for their achievement and the maintenance of the system.

MPI is a company in the dental sector dedicated to the design, development, manufacture, and sale of dental implant systems, prosthetic components, and surgical instruments; the import of anchorage systems for overdentures on implants; and the import of artificial bone.

As part of the continuous improvement process and to ensure innovation and quality management in product design, an Integrated Quality and R&D&I Management System (hereinafter SGI) has been implemented, which guarantees compliance with applicable legal and regulatory requirements established on Regulation 2017/745 and Royal Decree 192/2023 on medical devices to achieve customer and other stakeholders’ satisfaction and maintain the effectiveness of the implemented system.

MPI is certified under ISO 13485:2016 to ensure the implemented Management System and under UNE 166002:2021 to validate the effectiveness of R&D&I projects. Annual audits are conducted by a Certifying Body and a Notified Body to ensure compliance with standard requirements.

Management performs an annual review of the established policy to ensure its implementation and maintenance. This policy is communicated internally to all MPI employees, ensuring that everyone understands it.

This policy is available as documented information in MPI’s SGI and is accessible; to enhance MPI’s reputation and attract relevant stakeholders, it is available to all interested parties upon request.

Madrid, September 4^th, 2025

Version: 4